Dronabinol
Key facts
Active substance |
Dronabinol
|
Therapeutic area |
Pain
|
Decision number |
P/214/2010
|
PIP number |
Dronabinol
|
Pharmaceutical form(s) |
Oral solution
|
Condition(s) / indication(s) |
Treatment of central and peripheral neuropathic pain
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Bionorica AG
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|